中文

R&D 

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address:8888 Lvyou Road, Jinan, Shandong 250104, CHINA

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

Qilu Pharma got CEP for Ondansetron HCl

Classification:
Company news
Author:
Source:
Release time:
2009/12/28 00:00
Page view
[Abstract]:

Recently, we received CEP for Ondansetron HCl from EDQM. It is the second CEP granted to Qilu Pharma this year while the other is for Terbinafine HCl.

EDQM issued the certificate based on the review of our DMF without site inspection. It demonstrate that Qilu has a very strong capability on regulatory affairs and quality management.

NEWS